Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic St...
Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer
About this item
Full title
Author / Creator
the Philadelphia Bone Marrow Transplant Group , Stadtmauer, Edward A , O'Neill, Anne , Goldstein, Lori J , Crilley, Pamela A , Mangan, Kenneth F , Ingle, James N , Brodsky, Isadore , Martino, Silvana , Lazarus, Hillard M , Erban, John K , Sickles, Cheryl , Luger, Selina M , Klumpp, Thomas R , Litzow, Mark R , Topolsky, David L and Glick, John H
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Most women with metastatic breast cancer have a response to various combinations of conventional-dose chemotherapy, but less than 5 percent of them are alive 10 years after the detection of metastatic spread.
1
Several phase 2 trials performed in the late 1980s reported promising results for high-dose chemotherapy followed by autologous hemat...
Alternative Titles
Full title
Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer
Authors, Artists and Contributors
Author / Creator
Stadtmauer, Edward A
O'Neill, Anne
Goldstein, Lori J
Crilley, Pamela A
Mangan, Kenneth F
Ingle, James N
Brodsky, Isadore
Martino, Silvana
Lazarus, Hillard M
Erban, John K
Sickles, Cheryl
Luger, Selina M
Klumpp, Thomas R
Litzow, Mark R
Topolsky, David L
Glick, John H
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_17517825
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17517825
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJM200004133421501
